Table 1.
Formulation | Original | pH = 5 | With druga | |||
---|---|---|---|---|---|---|
Size(nm)/P.I. | Zeta potential (mV) | Size(nm)/P.I. | Zeta potential (mV) | Size(nm)/P.I. | Zeta potential (mV) | |
ME-O | 50.3/0.21 | −1.1 | — | — | 53.5/0.22 | −1.9 |
ME-W | 43.4/0.20 | −2.5 | 42.0/0.18 | −2.7 | 47.8/0.22 | −2.5 |
ME-Wphy | 50.7/0.18 | −4.3 | 53.2/0.21 | +29.1 | 54.8/0.18 | +20.1 |
P.I., polidispersity index. aSize and zeta potential for ME-O containing drug were determined at the original pH, whereas these parameters for ME-W and ME-Wphy were determined after pH adjustment to 5.